Atossa Therapeutics, Inc.
ATOS
$0.7775
$0.03354.50%
NASDAQ
06/30/2025 | 03/31/2025 | ||||
---|---|---|---|---|---|
Revenue | -- | -- | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -- | -- | |||
Cost of Revenue | -- | -- | |||
Gross Profit | -- | -- | |||
SG&A Expenses | 8.63% | -13.10% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 21.93% | 3.68% | |||
Operating Income | -21.93% | -3.68% | |||
Income Before Tax | -25.38% | -5.85% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | -25.38% | -5.85% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -25.38% | -5.85% | |||
EBIT | -21.93% | -3.68% | |||
EBITDA | -21.94% | -3.68% | |||
EPS Basic | -25.38% | -3.79% | |||
Normalized Basic EPS | -25.54% | -3.83% | |||
EPS Diluted | -25.38% | -3.79% | |||
Normalized Diluted EPS | -25.54% | -3.83% | |||
Average Basic Shares Outstanding | 0.00% | 2.02% | |||
Average Diluted Shares Outstanding | 0.00% | 2.02% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |